BB-22 powder

BB-22 is a potent synthetic cannabinoid which has been identified in smoking mixtures. BB-22 is an analog of JWH 018 that is structurally similar to PB-22 and its derivative, 5-fluoro PB-22 . Both BB-22 and PB-22 are distinctive in that an 8-hydroxyquinoline replaces the naphthalene group of JWH 018.

The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.

This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements.

All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

BB-22 acts as a full agonist with a binding affinity of 0.217nM at CB1 and 0.338nM at CB2 cannabinoid receptors. BB-22 is a synthetic cannabinoid and an analog of JWH 018.

This certified solution is suitable as starting material for calibrators or controls in synthetic cannabinoid GC/MS or LC/MS methods for urine drug testing, forensic analysis, or clinical toxicology applications.

For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.